Ancora Advisors’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Ancora Advisors’s Portfolio PGNX Stock Details PGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-57,700	Closed	-$219K	–	1501
2020 Q1	$219K	Buy	+57,700	New	+$249K	0.01%	632

Other funds holding PGNX

ECM

Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Ancora Advisors's PGNX Position: Q2 2020 in Review

Ancora Advisors sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 57,700 shares — an estimated $219K sold.

Ancora Advisors first reported a position in PGNX in Q1 2020 and held it in 1 quarter. The position peaked at $219K in Q1 2020. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.

Ancora Advisors reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
Ancora Advisors sold 57,700 Progenics Pharmaceuticals Inc shares in Q2 2020, an estimated $219K.
Ancora Advisors first reported a position in Progenics Pharmaceuticals Inc in Q1 2020 and held it in 1 quarter.
Ancora Advisors's Progenics Pharmaceuticals Inc position peaked at $219K in Q1 2020.
3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.

Based on Ancora Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.